Forest, Belgium

Jack Elands

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Centre National De La Recherche Scientifique, Emergence Therapeutics Gmbh, Institut Jean Paoli & Irène Calmettes. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jack Elands - Innovator in Antibody Development

Introduction

Jack Elands is a notable inventor based in Forest, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.

Latest Patents

Jack Elands holds 1 patent for his invention titled "Anti-nectin-4-antibodies and uses thereof." This patent relates to antibodies that specifically target Nectin-4, along with their various applications in therapeutic settings. His research aims to enhance the efficacy of treatments involving these antibodies.

Career Highlights

Throughout his career, Jack has worked with prominent organizations, including Emergence Therapeutics GmbH and Université D'Aix-Marseille. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jack has collaborated with notable colleagues such as Florence L'Hospice and Xavier Préville. Their combined expertise has fostered an environment of innovation and discovery in the realm of antibody research.

Conclusion

Jack Elands is a distinguished inventor whose work in antibody development showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options that could benefit many patients in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…